 |
|
|
| |
Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least seven days
|
| |
| |
Reported by Jules Levin
9th IAS Conference on HIV Science (IAS 2017), July 23-26, 2017, Paris
IAS: MK-8591 Protects 8 of 8 Macaques From Rectal SHIV 6 Days After Dosing - (07/23/17)
Randolph P. Matthews1, Dirk Schurmann2, Deanne Jackson Rudd1, Vanessa Levine1, Sabrina Fox-Bosetti1, Sandra Zhang1, Martine Robberechts1, Inge De Lepeleire1, Andreas Huser2, Daria J. Hazuda1, Marian Iwamoto1, and Jay A. Grobler1 on behalf of the HIV Early Development Team. 1MSD, Kenilworth, NJ, USA; 2Charité Research Organisation, Berlin, Germany.
|
| |
|
|
|
|
|
